latest news releases from the newsroom
Mymetics Corporation Announces Initiation of Research Coverage by Khandaker Partners
NYON, Switzerland, Dec. 3, 2008 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX) announced today that Khandaker Partners has initiated coverage (www.mymetics.com) with an intermediate term price range of $1.20 for its common stock. Mymetics is a Swiss biotech company with a mucosal AIDS vaccine candidate entering Human Clinical Phase I trials and a long term Malaria vaccine in Phase II Human Clinical trials.
SmallCap Sentinel: Separation From the Pack Among Chinese Stocks
IRVINE, Calif., Dec. 3, 2008 (GLOBE NEWSWIRE) -- There was a time when the stock market was ravenously searching for the next red-hot Chinese stock play as if they were dot-coms in 1999. Investors and venture capital firms were chasing the next-big-thing in U.S.-listed, Asian-based equities across the board and it seemed there was a deluge of said companies hitting American exchanges.